Celsus Therapeutics

Celsus Therapeutics Plc is a development-stage biopharmaceutical company dedicated to the discovery and development of non-steroidal synthetic anti-inflammatory drugs. The company's lead candidate product is MRX-6, a topical cream currently in Phase 2 clinical trials for the treatment of atopic dermatitis.